Novartis, Shire issue pink slips

Share this article:

Vivus is just one of a slate of companies that recently announced they were reducing workforce. The Boston Globe reports that Novartis has added 500 pink slips to that pile, pulling jobs from a research program in California, while at the same time opening 175 positions in Cambridge, MA. The Globe notes that Cambridge's gain somewhat offsets the recent announcement that Vertex was releasing employees, due to a hazardous HCV sales environment.

Shire is also cutting jobs. Reuters reports the specialty drugmaker is cutting around 180 R&D jobs at its Basingstoke, UK, office, where it has 520 people on-staff. The streamlining is part of the company's “One Shire” initiative.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.